Stay updated on FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4 on the page, indicating a newer version of the content.
    Difference
    0.0%
    Check dated 2026-05-18T03:44:50.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The version/release label at the bottom of the page was updated from Revision: v3.5.0 to Revision: v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T08:21:30.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Location in Italy updated from Padua to Padova (35128); the Padova site is now listed and the Padua listing removed.
    Difference
    0.0%
    Check dated 2026-04-04T19:00:47.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No changes to study data or page layout.
    Difference
    0.0%
    Check dated 2026-03-21T08:46:55.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; this seems to be a small internal site update with no visible changes to study content.
    Difference
    0.0%
    Check dated 2026-03-06T18:33:07.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Gastric cancer added as a related topic/keyword and Genetic and Rare Diseases Information Center resources linked; the page revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:41:49.000Z thumbnail image

Stay in the know with updates to FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.